Page last updated: 2024-10-22

aminoglutethimide and Prostatic Hyperplasia

aminoglutethimide has been researched along with Prostatic Hyperplasia in 1 studies

Aminoglutethimide: An aromatase inhibitor that is used in the treatment of advanced BREAST CANCER.
aminoglutethimide : A dicarboximide that is a six-membered cyclic compound having ethyl and 4-aminophenyl substituents at the 3-position.

Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.

Research Excerpts

ExcerptRelevanceReference
"Sections of benign prostatic hyperplasia and prostatic carcinoma from each patient were stained with antibodies to AR and GR using an avidin-biotin peroxidase technique."1.29Androgen and glucocorticoid receptors in the stroma and epithelium of prostatic hyperplasia and carcinoma. ( Chen, Y; Cidlowski, JA; French, FS; Hall, SH; Hamil, K; Mohler, JL; Sar, M; Wilson, EM, 1996)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mohler, JL1
Chen, Y1
Hamil, K1
Hall, SH1
Cidlowski, JA1
Wilson, EM1
French, FS1
Sar, M1

Other Studies

1 other study available for aminoglutethimide and Prostatic Hyperplasia

ArticleYear
Androgen and glucocorticoid receptors in the stroma and epithelium of prostatic hyperplasia and carcinoma.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1996, Volume: 2, Issue:5

    Topics: Aged; Aminoglutethimide; Epithelial Cells; Humans; Immunohistochemistry; Ketoconazole; Male; Middle

1996